Details of the Drug Reposition

General Information of This Drug (ID: DMJQXFA)

Drug Name
NA-831   DMJQXFA
Synonyms traneurocin
Drug Type
Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Coronavirus Disease 2019 (COVID-19) DISM7GNX 1D6Y Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cognitive impairment DISH2ERD 6D71 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04540185) A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03538522) A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831. U.S. National Institutes of Health.